p57KIP2 Modulates Stress-activated Signaling by Inhibiting c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase
Open Access
- 1 November 2003
- journal article
- Published by Elsevier
- Vol. 278 (48) , 48092-48098
- https://doi.org/10.1074/jbc.m309421200
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to developmentCurrent Opinion in Cell Biology, 1998
- Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndromeNature, 1997
- Cdk inhibitors in development and cancerCurrent Opinion in Genetics & Development, 1996
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.Genes & Development, 1995
- Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Genes & Development, 1995
- Principles of CDK regulationNature, 1995
- Transcription Factor ATF2 Regulation by the JNK Signal Transduction PathwayScience, 1995
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainPublished by Elsevier ,1994